Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance

Chest

Volumn 114, Issue 3, 1998, Pages 780-786

  Haraldsson, Åsa ^a   Kieler Jensen, Niels ^a   Nathorst Westfelt, Ulla ^a   Bergh, Claes Håkan ^a   Ricksten, Sven Erik ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aerosolized prostacyclin; Heart transplantation; Inhalation; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART OUTPUT; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NEBULIZER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0031667399     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.3.780     Document Type: Article

References (41)

1. Griepp RB, Stinson EB, Dong EJ, et al. Determinants of operative risk in human heart transplantation. Am J Surg 1971; 22:192-197
2. Addonizio LJ, Gersony WM, Robbins RC, et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 1987; 76(suppl V):V-52-55
3. Kirklin JK, Naftel DC, Kirklin JW, et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1988; 7:331-336
4. Murali S, Uretsky BF, Reddy PS, et al. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J 1991; 122:5:1375-1381
5. Erickson KW, Costanzo-Nordin MR, O'Sullivan EJ, et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Lung Transplant 1990; 9:526-537
6. Costard-Jäckle A, Hill I, Schroeder JS, et al. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 1991; 84(suppl III):III-329-III-337
7. Kieler-Jensen N, Milocco I, Ricksten S-E. Pulmonary vasodilation after heart transplantation: a comparison among prostacyclin, sodium nitroprusside and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart Lung Transplant 1993; 12:179-184
8. Kieler-Jensen N, Ricksten S-E, Stenqvist O, et al. Inhaled nitric oxide in the evaluation of heart-transplant candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 1994; 13:366-375
9. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43:109-142
10. Girard C, Lehot JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77:880-883
11. Rich GF, Murphy JGD, Ross CM, et al. Inhaled nitric oxide: selective pulmonary vasodilation in cardiac surgical patients. Anesthesiology 1993; 78:1028-1035
12. Powell M. Toxic fumes from shotfireing in coal mines. Ann Occup Hyg 1961; 3:162-183
13. Stenquist O, Kjelltoft B, Lundin S. Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand 1993; 37:687-691
14. Ferreira SH, Vane JR. Prostaglandins: their disappearance from and release into the circulation. Nature 1967; 216:868-873
15. Data JL, Molony BA, Meinzinger MM, et al. Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3:5-cyclic monophosphate levels. Circulation 1981; 64:4-12
16. Moncada S. Biology and therapeutic potential of prostacyclin. Stroke 1983; 14(No. 2):157-168
17. Haraldsson Å, Kieler-Jensen N, Ricksten S-E. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 1996; 10:864-868
18. Walmrath D, Schneider T, Pilch J, et al. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342:961-962
19. Walmrath D, Schneider T, Pilch J, et al. Effects of aerosolized prostacyclin in severe pneumonia: impact of fibrosis. Am J Respir Crit Care Med 1995; 151:724-730
20. Zwissler B, Welte M, Messmer K. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth 1995; 9:283-289
21. Zobel G. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res 1995; 38:198-204
22. Walmrath D, Schneider R, Schermuly R, et al. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 153:991-995
23. Tabachnick B, Fidell L. Profile analysis of repeated measures. In: Using multivariate statistics. 2nd ed. New York: Harper Collins, 1989;437-505
24. Metsa-Ketela T. Cyclic AMP-dependent and independent effects of prostaglandins on the contraction-relaxation cycle of spontaneously beating isolated rat atria. Acta Physiol Scand 1981; 112:481-485
25. Sterin-Borda L, Canza L, Borda ES. Inotropic effects of prostacyclin on isolated right atria of different contraction frequencies. Arch Pharmacol 1980; 313:95-100
26. Chelly J, Fabiani J-N, Chahine R, et al. Hemodynamic and metabolic effects of prostacyclin after coronary bypass surgery. Circulation 1982; 66:45-49
27. Kieler-Jensen N, Houltz E, Milocco I, et al. Central hemodynamics and right ventricular function after coronary artery bypass surgery: a comparison of prostacyclin, sodium nitroprusside and nitroglycerin for treatment of postcardiac surgical hypertension. J Cardiothorac Vasc Anesth 1993; 7:555-559
28. 2-aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 1993; 25:329-340
29. Pappert D, Busch T, Gerlach H, et al. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome. Anesthesiology 1995; 82:1507-1511
30. Fratacci M-D, Frostell CG, Chen T-Y, et al. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75:990-999
31. Frostell CG, Blomquist H, Hedenstierna G, et al. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilatation. Anesthesiology 1993; 78:427-435
32. Girard C, Durand PG, Vedrinne C, et al. Inhaled nitric oxide for right ventricular failure after heart transplantation: case conference. J Cardiothorac Vasc Anesth 1993; 7:481-485
33. 1 and sodium nitroprusside. J Heart Lung Transplant 1995; 14:436-443
34. Loh E, Stamler JS, Hare JM, et al. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 1994; 90:2780-2780
35. Semigran MJ, Cockrill BA, Kacmarek R, et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994; 24:982-988
36. Benzing A, Geiger K. Inhaled nitric oxide lowers pulmonary capillary pressure and changes longitudinal distribution of pulmonary vascular resistance in patients with acute lung injury. Acta Anaesthesiol Scand 1994; 38:640-645
37. Hare JM, Shernan SK, Body SC, et al. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressures in patients receiving mechanical circulatory assistance. Circulation 1997; 95:2250-2253
38. Vlahakas GJ, Turley K, Hoffman JIE. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87-95
39. Olschewski H. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124:820-824
40. Burghuber O, Silberbauer K, Haber P, et al. Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration 1984; 45:450-454
41. 2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 1996; 22:426-433